Clinical trial
Personalized Anticoagulant Therapy for Pulmonary Thromboembolism in Specific Populations With Older Age, Renal Insufficiency or Co-existing Malignancy
NCT06341231 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Anticoagulant Therapy for Pulmonary Thromboembolism in Specific Populations With Older Age, Renal Insufficiency or Co-existing Malignancy
- Lead sponsor
- Xiangya Hospital of Central South University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2024
- Completion date
- December 31, 2027
- Enrollment
- 4,700 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulants; increased, pulmonary thromboembolisms